Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Illerhaus

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Annals of Hematology|March 30, 2012
The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patientsBenjamin Kasenda, Marcel Rehberg, Petra Thürmann, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 23, 2022
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MSPatrick Opitz, Sebastian Zimmermann, Anna M Mc Laughlin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 20, 2012
18F-FDG PET is an independent outcome predictor in primary central nervous system lymphomaBenjamin Kasenda, Vanessa Haug, Elisabeth Schorb, et al.
Haematologica|January 23, 2025
Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphomaJulia Wendler, Richard I Lewis, Alexandra Kutilina, et al.
British Journal of Cancer|September 4, 2015
Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancerAlexander Stein, Djordje Atanackovic, Bert Hildebrandt, et al.
Frontiers in Digital Health|December 12, 2025
Optimized BERT-based NLP outperforms zero-shot methods for automated symptom detection in clinical practiceJuan G Diaz Ochoa, Natalie Layer, Jonas Mahr, et al.
BMC Cancer|August 18, 2012
Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literatureAlexander Stein, Gabriel Glockzin, Andreas Wienke, et al.
Cancers|February 13, 2026
The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous SystemJulia Wendler, Benjamin Kasenda, Eliza M Lauer, et al.
Nature Reviews. Disease Primers|June 15, 2023
Primary central nervous system lymphomaAndrés J M Ferreri, Teresa Calimeri, Kate Cwynarski, et al.
Cancers|December 11, 2025
Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS LymphomaLisa K Isbell, Annika Vreden, Gabriele Ihorst, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Annals of Hematology|March 30, 2012
The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patientsBenjamin Kasenda, Marcel Rehberg, Petra Thürmann, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 23, 2022
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MSPatrick Opitz, Sebastian Zimmermann, Anna M Mc Laughlin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 20, 2012
18F-FDG PET is an independent outcome predictor in primary central nervous system lymphomaBenjamin Kasenda, Vanessa Haug, Elisabeth Schorb, et al.
Haematologica|January 23, 2025
Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphomaJulia Wendler, Richard I Lewis, Alexandra Kutilina, et al.
British Journal of Cancer|September 4, 2015
Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancerAlexander Stein, Djordje Atanackovic, Bert Hildebrandt, et al.
Frontiers in Digital Health|December 12, 2025
Optimized BERT-based NLP outperforms zero-shot methods for automated symptom detection in clinical practiceJuan G Diaz Ochoa, Natalie Layer, Jonas Mahr, et al.
BMC Cancer|August 18, 2012
Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literatureAlexander Stein, Gabriel Glockzin, Andreas Wienke, et al.
Cancers|February 13, 2026
The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous SystemJulia Wendler, Benjamin Kasenda, Eliza M Lauer, et al.
Nature Reviews. Disease Primers|June 15, 2023
Primary central nervous system lymphomaAndrés J M Ferreri, Teresa Calimeri, Kate Cwynarski, et al.
Cancers|December 11, 2025
Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS LymphomaLisa K Isbell, Annika Vreden, Gabriele Ihorst, et al.
Pageof 8